Nanocurcumin as an Add-on to Antipsychotic Drugs for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study.

Hosseininasab, Masumeh; Zarghami, Mehran; Mazhari, Shahrzad; Salehifar, Ebrahim; Moosazadeh, Mahmood; Fariborzifar, Arghavan; Babaeirad, Sareh; Hendouei, Narjes

Hosseininasab, Masumeh; Zarghami, Mehran; Mazhari, Shahrzad; Salehifar, Ebrahim; Moosazadeh, Mahmood; Fariborzifar, Arghavan; Babaeirad, Sareh; Hendouei, Narjes.

Afiliação

Hosseininasab M; From the Department of Pharmacotherapy, Student Research Committee, Faculty of Pharmacy, Mazandaran University of Medical Sciences.
Mazhari S; Neuroscience Research Center; Psychiatric Department, School of Medicine, Kerman University of Medical Sciences, Kerman.
Salehifar E; Department of Pharmacotherapy, Faculty of Pharmacy, Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences.
Moosazadeh M; Epidemiology, Gastrointestinal Cancer Research Center, Health Sciences Research Center, Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences.

J Clin Psychopharmacol ; 41(1): 25-30, 2021.

Article em En | MEDLINE | ID: mdl-33347019

Assuntos

Antipsicóticos/efeitos adversos; Curcumina/efeitos adversos; Curcumina/uso terapêutico; Esquizofrenia/tratamento farmacológico; Adulto; Método Duplo-Cego; Quimioterapia Combinada; Humanos; Masculino; Pessoa de Meia-Idade; Resultado do Tratamento

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Curcumina Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google